FLT3 and acute myeloid leukemia: We performed initial comparison of our optimized pHASED protocol with traditional single-shot LFQ phosphoproteomics using three isogenic cell line models of FLT3-mutant AML in biological triplicate (Table 1; n = 9 samples/experiment).